|

Predictors of Decompensation, Acute-on-chronic Liver Failure and Mortality in Liver Cirrhosis

RECRUITINGSponsored by Singapore General Hospital
Actively Recruiting
SponsorSingapore General Hospital
Started2022-08-12
Est. completion2027-08-12
Eligibility
Age18 Years+
Healthy vol.Accepted

Summary

The purpose of this study is to identify factors that predict the development of decompensation, acute-on-chronic liver failure (ACLF) and death in patients with liver cirrhosis. Clinical data will be retrieved from existing hospital records. This information may help doctors to identify patients with cirrhosis who are at risk of deterioration earlier (before they develop complications) and to develop effective treatment strategies to prevent or delay these complications. This study is designed as a prospective, non-interventional, observational study. This means that if you agree to participate in the study, you will not be required to undergo any additional hospital visits, tests, procedures or interventions other than the usual standard-of-care management that your doctor will provide. If you consent to participate in this study, you will be providing the study investigators permission to review and analyse your clinical data from the hospital clinical records. Your data will be collected throughout the course of your disease until liver transplantation or death.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

1. Patients with clinical diagnosis of liver cirrhosis
2. Age 18 years and above (parental consent required if below 21 years)
3. Willing and able to provide informed consent

Exclusion Criteria:

* No clinical evidence of liver cirrhosis
* Not willing to provide informed consent

Conditions2

Cirrhosis and Chronic Liver DiseaseLiver Disease

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.